 |
|
Clinicopathological role of kidney injury molecule-1 in immunoglobulin A nephropathy
Yu Ho Lee, Yang-Gyun Kim, Sang-Ho Lee, Ju-Young Moon, Kyung-Hwan Jeong, Tae-Won Lee, Chun-Gyoo Ihm
Kidney Res Clin Pract. 2014;33(3):139-143. Published online 2014 Sep 5 DOI: https://doi.org/10.1016/j.krcp.2014.07.004
|
|
Citations to this article as recorded by
 Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy
Jorge González Rodríguez, Jose Manuel Valdivielso, Elías Jatem Escalante, Mercè Borràs Sans, Alicia García Carrasco, Jacqueline Del Carpio Salas, Andrea Muijsenberg Alcalá, Miquel Pinyol Ribas, Elena Ostos Roldán, Alfons Segarra Medrano, Maria Luisa Martí
BMC Nephrology.2025;[Epub] CrossRef IgA Vasculitis and IgA Nephropathy: Two Sides of the Same Coin?
Evangéline Pillebout
Seminars in Nephrology.2024; 44(5): 151571. CrossRef The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study
Balázs Sági, Tibor Vas, Csenge Gál, Zoltán Horváth-Szalai, Tamás Kőszegi, Judit Nagy, Botond Csiky, Tibor József Kovács
International Journal of Molecular Sciences.2024; 25(19): 10552. CrossRef Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
Haresh Selvaskandan, Sufang Shi, Sara Twaij, Chee Kay Cheung, Jonathan Barratt
Frontiers in Immunology.2020;[Epub] CrossRef Urinary kidney injury molecule-1 in renal disease
Rafael N. Moresco, Guilherme V. Bochi, Carolina S. Stein, José A.M. De Carvalho, Bibiana M. Cembranel, Yãnaí S. Bollick
Clinica Chimica Acta.2018; 487: 15. CrossRef Plasma endocan level and prognosis of immunoglobulin A nephropathy
Yu Ho Lee, Jin Sug Kim, Se-Yun Kim, Yang Gyun Kim, Ju-Young Moon, Kyung-Hwan Jeong, Tae Won Lee, Chun-Gyoo Ihm, Sang-Ho Lee
Kidney Research and Clinical Practice.2016; 35(3): 152. CrossRef
|